People over 65 taking once-daily oral orforglipron achieved substantial weight loss with a consistent safety profile, regardless of T2D status, in a post hoc ATTAIN trial analysis.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/oral-orforglipron-effective-older-adults-obesity-2026a1000fci?src=rss
Author :
Publish date : 2026-05-12 13:46:00
Copyright for syndicated content belongs to the linked Source.
